Latest Chemotherapy news
Immunochemotherapy Infusions Early in the Day Tied to Improved NSCLC Survival
posted February 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Addition of Palbociclib Improves PFS in HR-Positive, HER2-Positive Metastatic Breast Cancer
posted February 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Progression-Free Survival Prolonged With Sacituzumab Govitecan Plus Pembrolizumab in TNBC
posted January 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
ASCO GI: Zanidatamab + Chemo Beneficial in HER2-Positive Gastroesophageal Cancer
posted January 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Cancer Drug Shortages Persist at All Cancer Centers 
Relapse Rare After Appendiceal Adenocarcinoma Resection Related Articles
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Dexrazoxane Offers Lasting Doxorubicin Cardioprotective Effect in Childhood Cancer Survivors Monthly Specialist Briefings
Stay Connected
